Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.14
DRAD's Cash-to-Debt is ranked lower than
91% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. DRAD: 0.14 )
Ranked among companies with meaningful Cash-to-Debt only.
DRAD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.14  Med: 148.65 Max: No Debt
Current: 0.14
Equity-to-Asset 0.63
DRAD's Equity-to-Asset is ranked higher than
51% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. DRAD: 0.63 )
Ranked among companies with meaningful Equity-to-Asset only.
DRAD' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.23  Med: 0.8 Max: 0.85
Current: 0.63
-2.23
0.85
Interest Coverage 2.18
DRAD's Interest Coverage is ranked lower than
92% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 86.37 vs. DRAD: 2.18 )
Ranked among companies with meaningful Interest Coverage only.
DRAD' s Interest Coverage Range Over the Past 10 Years
Min: 2.18  Med: 10.39 Max: No Debt
Current: 2.18
Piotroski F-Score: 3
Altman Z-Score: 1.88
Beneish M-Score: -1.89
WACC vs ROIC
24.52%
17.29%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 2.46
DRAD's Operating Margin % is ranked higher than
50% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. DRAD: 2.46 )
Ranked among companies with meaningful Operating Margin % only.
DRAD' s Operating Margin % Range Over the Past 10 Years
Min: -11.73  Med: -1.88 Max: 4.56
Current: 2.46
-11.73
4.56
Net Margin % 11.40
DRAD's Net Margin % is ranked higher than
79% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. DRAD: 11.40 )
Ranked among companies with meaningful Net Margin % only.
DRAD' s Net Margin % Range Over the Past 10 Years
Min: -11.06  Med: -0.67 Max: 35.58
Current: 11.4
-11.06
35.58
ROE % 22.64
DRAD's ROE % is ranked higher than
92% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. DRAD: 22.64 )
Ranked among companies with meaningful ROE % only.
DRAD' s ROE % Range Over the Past 10 Years
Min: -13.31  Med: -0.87 Max: 49.86
Current: 22.64
-13.31
49.86
ROA % 14.18
DRAD's ROA % is ranked higher than
93% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. DRAD: 14.18 )
Ranked among companies with meaningful ROA % only.
DRAD' s ROA % Range Over the Past 10 Years
Min: -11.19  Med: -0.69 Max: 40.82
Current: 14.18
-11.19
40.82
ROC (Joel Greenblatt) % 9.89
DRAD's ROC (Joel Greenblatt) % is ranked higher than
57% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. DRAD: 9.89 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
DRAD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -52.2  Med: -9.31 Max: 34.16
Current: 9.89
-52.2
34.16
3-Year Revenue Growth Rate 34.40
DRAD's 3-Year Revenue Growth Rate is ranked higher than
94% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. DRAD: 34.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
DRAD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -90.7  Med: -3.5 Max: 35.4
Current: 34.4
-90.7
35.4
3-Year EBITDA Growth Rate 79.40
DRAD's 3-Year EBITDA Growth Rate is ranked higher than
95% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. DRAD: 79.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
DRAD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -92.6  Med: -41 Max: 79.4
Current: 79.4
-92.6
79.4
3-Year EPS without NRI Growth Rate 314.10
DRAD's 3-Year EPS without NRI Growth Rate is ranked higher than
99% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. DRAD: 314.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
DRAD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -92.9  Med: -20.6 Max: 314.1
Current: 314.1
-92.9
314.1
GuruFocus has detected 3 Warning Signs with Digirad Corp $DRAD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» DRAD's 10-Y Financials

Financials (Next Earnings Date: 2017-05-24 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

DRAD Guru Trades in Q1 2016

Jim Simons 924,200 sh (-0.22%)
» More
Q2 2016

DRAD Guru Trades in Q2 2016

Jim Simons 902,800 sh (-2.32%)
» More
Q3 2016

DRAD Guru Trades in Q3 2016

Jim Simons 863,300 sh (-4.38%)
» More
Q4 2016

DRAD Guru Trades in Q4 2016

Jim Simons 856,100 sh (-0.83%)
» More
» Details

Insider Trades

Latest Guru Trades with DRAD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:NAS:IRMD, NAS:MSON, NAS:CGNT, NAS:FONR, NAS:SPNE, NAS:NVCN, NAS:EDAP, OTCPK:PHMZF, NAS:NVTR, NAS:EYES, NAS:VIVE, NAS:PAVM, NAS:IRIX, NAS:TNDM, NAS:SPAN, NAS:SRTS, NAS:ACRX, OTCPK:AVMXF, OTCPK:IVOB, OTCPK:BLOZF » details
Traded in other countries:FDV.Germany,
Headquarter Location:USA
Digirad Corp provides nuclear cardiology imaging and ultrasound imaging services & cardiac event monitoring services. It also sells medical diagnostic imaging systems.

Digirad designs and sells nuclear technology for mobile cardiovascular imaging to doctors' offices and hospitals across the United States. The company commercialized the first nuclear gamma camera and offers its products through both sale and leasing options through its digital imaging solutions subsidiary. The company's gamma cameras range from single- to triple-head configuration, with imaging procedures topping 100,000 in 2007.

Ratios

vs
industry
vs
history
PE Ratio 6.61
DRAD's PE Ratio is ranked higher than
94% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 27.53 vs. DRAD: 6.61 )
Ranked among companies with meaningful PE Ratio only.
DRAD' s PE Ratio Range Over the Past 10 Years
Min: 2.94  Med: 16.76 Max: 192
Current: 6.61
2.94
192
PE Ratio without NRI 6.61
DRAD's PE Ratio without NRI is ranked higher than
94% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 27.51 vs. DRAD: 6.61 )
Ranked among companies with meaningful PE Ratio without NRI only.
DRAD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 2.94  Med: 16.76 Max: 192
Current: 6.61
2.94
192
Price-to-Owner-Earnings 14.96
DRAD's Price-to-Owner-Earnings is ranked higher than
78% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 32.96 vs. DRAD: 14.96 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
DRAD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 0.7  Med: 17.68 Max: 51.02
Current: 14.96
0.7
51.02
PB Ratio 1.42
DRAD's PB Ratio is ranked higher than
77% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. DRAD: 1.42 )
Ranked among companies with meaningful PB Ratio only.
DRAD' s PB Ratio Range Over the Past 10 Years
Min: 0.19  Med: 1.21 Max: 2.66
Current: 1.42
0.19
2.66
PS Ratio 0.74
DRAD's PS Ratio is ranked higher than
86% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. DRAD: 0.74 )
Ranked among companies with meaningful PS Ratio only.
DRAD' s PS Ratio Range Over the Past 10 Years
Min: 0.12  Med: 0.87 Max: 2.1
Current: 0.74
0.12
2.1
Price-to-Free-Cash-Flow 20.10
DRAD's Price-to-Free-Cash-Flow is ranked higher than
59% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 27.61 vs. DRAD: 20.10 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
DRAD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.95  Med: 25.16 Max: 168.89
Current: 20.1
4.95
168.89
Price-to-Operating-Cash-Flow 8.65
DRAD's Price-to-Operating-Cash-Flow is ranked higher than
86% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. DRAD: 8.65 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
DRAD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.5  Med: 16.74 Max: 401.67
Current: 8.65
3.5
401.67
EV-to-EBIT 37.41
DRAD's EV-to-EBIT is ranked lower than
74% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. DRAD: 37.41 )
Ranked among companies with meaningful EV-to-EBIT only.
DRAD' s EV-to-EBIT Range Over the Past 10 Years
Min: -24.1  Med: -2 Max: 203.1
Current: 37.41
-24.1
203.1
EV-to-EBITDA 9.03
DRAD's EV-to-EBITDA is ranked higher than
83% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. DRAD: 9.03 )
Ranked among companies with meaningful EV-to-EBITDA only.
DRAD' s EV-to-EBITDA Range Over the Past 10 Years
Min: -126.6  Med: 6.4 Max: 161
Current: 9.03
-126.6
161
Shiller PE Ratio 65.66
DRAD's Shiller PE Ratio is ranked lower than
72% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 49.41 vs. DRAD: 65.66 )
Ranked among companies with meaningful Shiller PE Ratio only.
DRAD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 62.86  Med: 83.58 Max: 194.33
Current: 65.66
62.86
194.33
Current Ratio 1.19
DRAD's Current Ratio is ranked lower than
85% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. DRAD: 1.19 )
Ranked among companies with meaningful Current Ratio only.
DRAD' s Current Ratio Range Over the Past 10 Years
Min: 1.12  Med: 4.41 Max: 5.32
Current: 1.19
1.12
5.32
Quick Ratio 0.93
DRAD's Quick Ratio is ranked lower than
82% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. DRAD: 0.93 )
Ranked among companies with meaningful Quick Ratio only.
DRAD' s Quick Ratio Range Over the Past 10 Years
Min: 0.89  Med: 3.97 Max: 4.66
Current: 0.93
0.89
4.66
Days Inventory 21.89
DRAD's Days Inventory is ranked higher than
94% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. DRAD: 21.89 )
Ranked among companies with meaningful Days Inventory only.
DRAD' s Days Inventory Range Over the Past 10 Years
Min: 21.1  Med: 40.36 Max: 54.41
Current: 21.89
21.1
54.41
Days Sales Outstanding 42.19
DRAD's Days Sales Outstanding is ranked higher than
87% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. DRAD: 42.19 )
Ranked among companies with meaningful Days Sales Outstanding only.
DRAD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.31  Med: 42.27 Max: 48.9
Current: 42.19
39.31
48.9
Days Payable 26.51
DRAD's Days Payable is ranked lower than
81% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. DRAD: 26.51 )
Ranked among companies with meaningful Days Payable only.
DRAD' s Days Payable Range Over the Past 10 Years
Min: 6.32  Med: 13.32 Max: 26.51
Current: 26.51
6.32
26.51

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 4.26
DRAD's Dividend Yield % is ranked higher than
90% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 1.33 vs. DRAD: 4.26 )
Ranked among companies with meaningful Dividend Yield % only.
DRAD' s Dividend Yield % Range Over the Past 10 Years
Min: 1.3  Med: 4.04 Max: 5.45
Current: 4.26
1.3
5.45
Dividend Payout Ratio 0.28
DRAD's Dividend Payout Ratio is ranked higher than
78% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 0.40 vs. DRAD: 0.28 )
Ranked among companies with meaningful Dividend Payout Ratio only.
DRAD' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.18  Med: 0.91 Max: 5
Current: 0.28
0.18
5
3-Year Dividend Growth Rate 58.70
DRAD's 3-Year Dividend Growth Rate is ranked higher than
95% of the 81 Companies
in the Global Medical Devices industry.

( Industry Median: 8.00 vs. DRAD: 58.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
DRAD' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 58.7
Current: 58.7
0
58.7
Forward Dividend Yield % 3.85
DRAD's Forward Dividend Yield % is ranked higher than
90% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. DRAD: 3.85 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 4.26
DRAD's 5-Year Yield-on-Cost % is ranked higher than
78% of the 219 Companies
in the Global Medical Devices industry.

( Industry Median: 1.97 vs. DRAD: 4.26 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
DRAD' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.3  Med: 4.04 Max: 5.45
Current: 4.26
1.3
5.45
3-Year Average Share Buyback Ratio -2.40
DRAD's 3-Year Average Share Buyback Ratio is ranked higher than
59% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. DRAD: -2.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
DRAD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1344.4  Med: -0.85 Max: 0.6
Current: -2.4
-1344.4
0.6

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 1.93
DRAD's Price-to-Tangible-Book is ranked higher than
74% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. DRAD: 1.93 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
DRAD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.23  Med: 1.38 Max: 2.83
Current: 1.93
0.23
2.83
Price-to-Intrinsic-Value-Projected-FCF 1.27
DRAD's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
74% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. DRAD: 1.27 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
DRAD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.06  Med: 1.97 Max: 2.72
Current: 1.27
0.06
2.72
Price-to-Median-PS-Value 0.86
DRAD's Price-to-Median-PS-Value is ranked higher than
60% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. DRAD: 0.86 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
DRAD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.02  Med: 0.91 Max: 2.15
Current: 0.86
0.02
2.15
Price-to-Graham-Number 0.75
DRAD's Price-to-Graham-Number is ranked higher than
91% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. DRAD: 0.75 )
Ranked among companies with meaningful Price-to-Graham-Number only.
DRAD' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.72  Med: 1.83 Max: 13.62
Current: 0.75
0.72
13.62
Earnings Yield (Greenblatt) % 2.67
DRAD's Earnings Yield (Greenblatt) % is ranked higher than
55% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. DRAD: 2.67 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
DRAD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.5  Med: 4.3 Max: 475
Current: 2.67
0.5
475

More Statistics

Revenue (TTM) (Mil) $125.5
EPS (TTM) $ 0.71
Beta2.36
Short Percentage of Float0.57%
52-Week Range $4.15 - 6.15
Shares Outstanding (Mil)19.98
» More Articles for DRAD

Headlines

Articles On GuruFocus.com
Bargain Stocks With High Dividend Yields Apr 24 2017 
Digirad Corporation to Release 2017 First Quarter Financial Results on April 28, 2017 Apr 11 2017 
Platinum Equity to Sell DMS Health Technologies to Digirad Corporation Oct 14 2015 
Top 3 Insider Buys Highlighted by Energy Companies Jul 12 2013 
DRAD Directors Increase Their Stake in the Medical Supply Company Apr 25 2013 
Expansion Initiates Insider Buying for NTS Apr 11 2013 
Digirad Corp. Reports Operating Results (10-K/A) Jul 30 2010 
Digirad Corp. Reports Operating Results (10-Q) Jul 29 2010 
Digirad Corp. Reports Operating Results (10-Q) Apr 29 2010 
Digirad Corporation Q3 2009 update Oct 29 2009 

More From Other Websites
Edited Transcript of DRAD earnings conference call or presentation 28-Apr-17 3:00pm GMT Apr 28 2017
Investor Network: Digirad Corporation to Host Earnings Call Apr 28 2017
Digirad reports 1Q loss Apr 28 2017
Digirad Corporation Reports Financial Results for the First Quarter Ended March 31, 2017 Apr 28 2017
Digirad Corporation to Release 2017 First Quarter Financial Results on April 28, 2017 Apr 11 2017
ETFs with exposure to Digirad Corp. : April 5, 2017 Apr 05 2017
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations... Mar 22 2017
Digirad Corp. :DRAD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 15, 2017 Mar 15 2017
Digirad Corporation to Present at the 29th Annual ROTH Conference on March 14, 2017 Feb 28 2017
Digirad Corporation (DRAD) Looks Good: Stock Jumps 10% Feb 27 2017
Digirad posts 4Q profit Feb 24 2017
Digirad Corporation Reports Financial Results for the Fourth Quarter and Twelve Months ended... Feb 24 2017
Digirad Corporation to Release 2016 Fourth Quarter and Year-End Financial Results on February 24,... Feb 15 2017
Digirad Corporation Announces Quarterly Dividend of $0.05 Per Share Jan 31 2017
ETFs with exposure to Digirad Corp. : December 27, 2016 Dec 27 2016
Digirad Corporation (DRAD): Are Hedge Funds Right About This Stock? Dec 14 2016
Digirad Corp. :DRAD-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016 Oct 31 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)